FSD Pharma Inc. announced the submission of the Company's Clinical Trial Application (CTA) for a planned Phase-1b clinical trial to Assess the Safety and Efficacy of unbuzzd? in Healthy Volunteers in an Induced State of Alcohol Intoxication (METAL-1 TRIAL). This clinical trial application is submitted for review by a human ethics review committee (HREC) in Australia, a first step to obtain permission to initiate the clinical trial.

Recruitment of healthy volunteers to this trial is expected to begin this April, following approval by the HREC. unbuzzd? is the dietary supplement product under development for potential marketing in the United States.

unbuzzd? is a fortified oral liquid formula with natural ingredients, vitamins and other food supplements that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism, and has the shown to accelerate the rate of alcohol metabolism in the body.